Download PDF
Thromb Haemost 2001; 85(03): 569-570
DOI: 10.1055/s-0037-1615630
Letters to the Editor
Schattauer GmbH

Factor XIII Activity and Antigen Levels in Patients with Coronary Artery Disease

Hans P. Kohler
1   Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK
,
Robert A. S. Ariëns
1   Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK
,
Michael W. Mansfield
1   Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK
,
Paul Whitaker
1   Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK
,
Peter J. Grant
1   Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK
› Author Affiliations
Further Information

Publication History

Received 09 October 2000

Accepted after resubmission 24 November 2000

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional crosslinking enzymes that stabilize tissues. FASEB J 1991; 5: 3071-77.
    CrossrefPubMedGoogle Scholar
  • 2 Kohler HP, Stickland MH, Ossei-Gerning N, Carter C, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Wartiovaara U, Perola M, Mikkola H, Tötterman K, Savolainen V, Penttilä A, Grant PJ, Tikkanen MJ, Vartiainen E, Karhunen PJ, Peltonen L, Palotie A. Association of FXIII Val34Leu with decreased risk of myocar-dial infarction in Finnish males. Atherosclerosis 1999; 142: 295-300.
    CrossrefPubMedGoogle Scholar
  • 4 Elbaz A, Poirier O, Canaple S, Chédru F, Cambien F, Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586-91.
    PubMedGoogle Scholar
  • 5 Kohler HP, Futers TS, Grant PJ. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease. Thromb Haemost 1999; 81: 511-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
    PubMedGoogle Scholar
  • 7 Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A, Bory M, Juhan-Vague I. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 2000; 83: 212-16.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Balogh I, Szoke G, Karpati L, Wartiovaara U, Katona E, Komaromi I, Haramura G, Pfliegler G, Mikkola H, Musbek L. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 2000; 96: 2479-86.
    PubMedGoogle Scholar
  • 9 Kohler HP, Ariens RAS, Whitaker P, Grant PJ. A common coding polymorphism in the factor XIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 1998; 80: 704.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Ariens RAS, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: Relation to gender, age, smoking and hypertension. Arterioscler Thromb Vasc Biol 1999; 19: 2012-16.
    CrossrefPubMedGoogle Scholar
  • 11 Trumbo TA, Maurer MC. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation. J Biol Chem 2000; 275: 20627-631.
    CrossrefPubMedGoogle Scholar
  • 12 Mansfield WM, Kohler HP, Ariëns RAS, McCormack LJ, Grant PJ. Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and their first-degree relatives. Diabetes Care 2000; 23: 703-4.
    CrossrefPubMedGoogle Scholar